1Croker AK, Allan AL. Cancer stem cells: implications for the progression and treatment of metastatic disease [J]. J Cell Mol Med,2008,12(2): 374-390.
2Luzzi KJ,MacDonald IC,Schmidt EE,et al. Multistep na- ture of metastatic inefficiency dormancy of solitary cells after successful extravasation and limited survival of early micrometastases[J].Am J Pathol, 1998,153(3):865-873.
3Nguyen DX,Bos PD,Massague J. Metastasis: from dissemination to organ-specific colonization [J]. Nat Rev Cancer, 2009,9(4): 274-284.
4Paget S. The distribution of secondary growths in cancer of the breast 1889[J]. Cancer Metastasis Rev, 1989,8(2):98-101.
5Yang J,Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis[J]. Dev Cell,2008,14(6): 818-829.
6Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors [J]. Clin Exp Metastasis,2008,25 (4): 345-356.
7Kim S,Takahashi H,Lin WW,et al.Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis[J]. Nature, 2009,457(7225): 102-106.
8Nguyen DX,Massague J. Genetic determinants of cancer metastasis[J]. Nat Rev Genet, 2007,8(5):341-352.
9Freudenberg JA,Wang Q,Katsumata M,et al. The role of HER2 in early breast eaneer metastasis and the origins of resistance to HER2-targeted therapies[J]. Exp Mol Pathol, 2009,87(1): 1-11.
10Wei -(,ffu G,Kang Y. Metadherin as a link between metastasis and chemoresistance[J]. Cell Cycle,2009,8(14): 2132-2133.
